The BAP1-tumor predisposition syndrome is the most studied genetic condition associated with MPM development and is caused by mutations in the BRCA1-associated protein 1 (BAP1) gene [14, 26–32]. The gene discussed is BAP1; the disease is BAP1-related tumor predisposition syndrome.